Naya Health has launched a clinic in London's Marylebone neighborhood to offer non-invasive brain stimulation to consumers. The company’s innovation uses transcranial magnetic stimulation technology to treat the neural circuits associated with chronic pain, anxiety, depression, burnout, migraines, Long Covid symptoms, ADHD, PTSD, OCD, peri and menopause symptoms, and compulsive behaviors. At its core, Naya Health’s non-invasive brain stimulation targets the underlying neurological patterns rather than managing individual symptoms in isolation.
The treatment is grounded in the principle of neuroplasticity, the brain's ability to change and adapt, and uses targeted magnetic pulses to encourage healthier neural activity, with each patient's progress tracked through a proprietary measurement system called NayaScore. The platform provides data-led visibility into changes in brain function over time.
The clinic was founded by Dan and Emily Honeywell after their personal experience supporting a family member with chronic fatigue and managing their own ADHD and anxiety.
Non-Invasive Brain Stimulation Clinics
Naya Health Debuts a Clinic in a London Neighborhood
Trend Themes
-
Data-driven Neurotherapeutics — Emerging platforms that pair non-invasive stimulation with proprietary scoring systems enable continuous quantification of neural change and new outcome-based care models.
-
Consumer-focused Brain Clinics — Clinics positioned in residential neighborhoods reflect a shift toward accessible, retail-style neurotherapy offerings that compete with traditional mental health and primary care services.
-
Tailored Neuroplasticity Treatments — Personalized stimulation protocols targeting circuit-level dysfunction suggest a move from symptom management to individualized rewiring therapies with measurable biomarkers.
Industry Implications
-
Mental Health Clinics — Specialist practices integrating device-based neuromodulation create opportunities to redefine care pathways for treatment-resistant conditions and reduce reliance on pharmacotherapy.
-
Medical Device Manufacturers — Developers of transcranial magnetic stimulators and wearables stand to commercialize compact, clinic-ready hardware and expand into consumer-facing treatment ecosystems.
-
Digital Health Analytics — Companies that provide longitudinal brain-function measurement and analytics can enable new reimbursement models and efficacy claims through objective outcome tracking.